| abstract |
The present invention provides compounds that are inhibitors or covalent modulators of succinate dehydrogenase subunit B (SDHB) and / or inhibitors of apoptosis and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are used in pharmaceutical compositions and methods of manufacture, and in methods of use that include treating those in need thereof with an effective amount of the compound or composition. |